Recent Advances in the Synthesis of Selenophenes and Their Derivatives.

Tytuł:: Recent Advances in the Synthesis of Selenophenes and Their Derivatives.
Autorzy:: Hellwig PS; Laboratório de Síntese Orgânica Limpa-LASOL-CCQFA, Universidade Federal de Pelotas-UFPel, P.O. Box 354, 96010-900 Pelotas, RS, Brazil.
Peglow TJ; Laboratório de Síntese Orgânica Limpa-LASOL-CCQFA, Universidade Federal de Pelotas-UFPel, P.O. Box 354, 96010-900 Pelotas, RS, Brazil.
Penteado F; Laboratório de Síntese Orgânica Limpa-LASOL-CCQFA, Universidade Federal de Pelotas-UFPel, P.O. Box 354, 96010-900 Pelotas, RS, Brazil.
Bagnoli L; Group of Catalysis, Synthesis and Organic Green Chemistry, Department of Pharmaceutical Sciences, University of Perugia, Via del Liceo 1, 06123 Perugia, Italy.
Perin G; Laboratório de Síntese Orgânica Limpa-LASOL-CCQFA, Universidade Federal de Pelotas-UFPel, P.O. Box 354, 96010-900 Pelotas, RS, Brazil.
Lenardão EJ; Laboratório de Síntese Orgânica Limpa-LASOL-CCQFA, Universidade Federal de Pelotas-UFPel, P.O. Box 354, 96010-900 Pelotas, RS, Brazil.
Źródło:: Molecules (Basel, Switzerland) [Molecules] 2020 Dec 13; Vol. 25 (24). Date of Electronic Publication: 2020 Dec 13.
Typ publikacji:: Journal Article; Review
Język:: English
Imprint Name(s):: Original Publication: Basel, Switzerland : MDPI, c1995-
MeSH Terms:: Chemistry Techniques, Synthetic*/methods
Chemistry Techniques, Synthetic*/trends
Heterocyclic Compounds/*chemical synthesis
Organoselenium Compounds/*chemical synthesis
Cyclization ; Heterocyclic Compounds/chemistry ; Heterocyclic Compounds/pharmacology ; Molecular Structure ; Organoselenium Compounds/chemistry ; Organoselenium Compounds/pharmacology
References:: Chem Commun (Camb). 2017 Jan 26;53(9):1542-1545. (PMID: 28094359)
J Org Chem. 2014 Jul 3;79(13):5987-92. (PMID: 24893620)
Chem Rev. 2009 Mar 11;109(3):1277-301. (PMID: 19222199)
J Org Chem. 2017 Mar 17;82(6):2906-2913. (PMID: 28220698)
Chemistry. 2013 Sep 23;19(39):13059-64. (PMID: 24038325)
Org Lett. 2019 May 17;21(10):3518-3522. (PMID: 31059274)
Org Lett. 2018 Nov 2;20(21):6650-6654. (PMID: 30350667)
J Org Chem. 2009 Feb 6;74(3):1141-7. (PMID: 19105638)
Dalton Trans. 2020 Mar 17;49(11):3393-3397. (PMID: 32129412)
J Med Chem. 2011 May 12;54(9):3418-25. (PMID: 21443219)
Brain Res Bull. 2009 Jun 30;79(5):281-7. (PMID: 19480988)
Pharmacol Biochem Behav. 2009 Oct;93(4):419-25. (PMID: 19538987)
Biochem Pharmacol. 2007 Mar 1;73(5):610-9. (PMID: 17150195)
Chemistry. 2020 Jul 8;26(38):8388-8392. (PMID: 32364628)
Org Lett. 2019 Jun 21;21(12):4605-4608. (PMID: 31145626)
Org Lett. 2019 Feb 15;21(4):1021-1025. (PMID: 30707588)
J Org Chem. 2018 Mar 16;83(6):3252-3264. (PMID: 29498282)
J Org Chem. 2018 Jun 15;83(12):6706-6718. (PMID: 29847130)
J Am Chem Soc. 2016 Jan 13;138(1):375-80. (PMID: 26652276)
J Am Chem Soc. 2007 Feb 28;129(8):2224-5. (PMID: 17279756)
J Phys Chem A. 2008 Jan 24;112(3):435-40. (PMID: 18166026)
J Org Chem. 2006 May 12;71(10):3786-92. (PMID: 16674051)
Org Lett. 2020 Apr 17;22(8):2987-2990. (PMID: 32216362)
J Org Chem. 2017 May 5;82(9):4588-4603. (PMID: 28414443)
ChemMedChem. 2019 Nov 20;14(22):1879-1886. (PMID: 31663667)
Chem Commun (Camb). 2013 Aug 18;49(64):7132-4. (PMID: 23828266)
Org Biomol Chem. 2020 Jun 7;18(21):4063-4070. (PMID: 32418998)
Org Biomol Chem. 2018 Jan 3;16(2):245-255. (PMID: 29238785)
Beilstein J Org Chem. 2017 Dec 22;13:2862-2868. (PMID: 29564014)
Org Lett. 2020 Jan 17;22(2):615-619. (PMID: 31909620)
Org Biomol Chem. 2011 Mar 7;9(5):1529-37. (PMID: 21225083)
ChemMedChem. 2020 Sep 16;15(18):1741-1751. (PMID: 32667720)
Medchemcomm. 2017 May 24;8(7):1485-1497. (PMID: 30108860)
Chem Commun (Camb). 2018 Feb 11;54(12):1517-1520. (PMID: 29364298)
Chem Commun (Camb). 2015 Nov 4;51(85):15522-5. (PMID: 26348229)
Org Lett. 2017 Dec 1;19(23):6292-6295. (PMID: 29160713)
Exp Mol Pathol. 2009 Aug;87(1):20-6. (PMID: 19344711)
J Am Chem Soc. 2006 Mar 8;128(9):3044-50. (PMID: 16506786)
Molecules. 2018 Feb 24;23(2):. (PMID: 29495287)
Chem Rev. 2011 Apr 13;111(4):2937-80. (PMID: 21425870)
Org Biomol Chem. 2018 May 23;16(20):3777-3787. (PMID: 29737350)
Chem Asian J. 2016 Jul 5;11(13):1929-38. (PMID: 27146245)
Chemistry. 2017 Feb 24;23(12):2788-2791. (PMID: 28093829)
J Org Chem. 2015 Apr 17;80(8):3880-90. (PMID: 25803565)
Org Biomol Chem. 2012 Jan 28;10(4):798-807. (PMID: 22120691)
Angew Chem Int Ed Engl. 2013 Sep 27;52(40):10496-9. (PMID: 23960030)
J Am Chem Soc. 2008 Dec 3;130(48):16187-9. (PMID: 18998651)
Org Biomol Chem. 2018 May 23;16(20):3721-3725. (PMID: 29737996)
Dalton Trans. 2011 Nov 21;40(43):11347-55. (PMID: 21904736)
J Am Chem Soc. 2004 Apr 28;126(16):5084-5. (PMID: 15099088)
Cell Biol Toxicol. 2010 Dec;26(6):569-77. (PMID: 20397041)
Neuropharmacology. 2014 Apr;79:580-9. (PMID: 24467850)
RSC Adv. 2020 May 19;10(32):19083-19087. (PMID: 35518303)
J Am Chem Soc. 2015 Jan 28;137(3):1314-21. (PMID: 25547347)
J Org Chem. 2019 Jul 5;84(13):8602-8614. (PMID: 31199146)
J Med Chem. 2020 Feb 27;63(4):1473-1489. (PMID: 31638805)
J Org Chem. 2006 Feb 17;71(4):1552-7. (PMID: 16468804)
Mol Cancer Ther. 2007 Jan;6(1):193-202. (PMID: 17237279)
ACS Nano. 2012 Aug 28;6(8):7114-21. (PMID: 22765232)
Bioorg Med Chem. 2017 Apr 15;25(8):2518-2523. (PMID: 28302505)
J Org Chem. 2006 Mar 17;71(6):2307-12. (PMID: 16526778)
J Org Chem. 2020 Mar 20;85(6):4553-4559. (PMID: 32133863)
Psychopharmacology (Berl). 2014 May;231(10):2119-30. (PMID: 24306280)
RSC Adv. 2019 Oct 11;9(56):32562-32572. (PMID: 35529715)
Inorg Chem. 2018 Sep 4;57(17):11027-11043. (PMID: 30129751)
Org Lett. 2017 Nov 3;19(21):5748-5751. (PMID: 29072469)
Tetrahedron Lett. 2017 Feb 15;58(7):638-641. (PMID: 29277842)
Eur J Pharmacol. 2014 Aug 5;736:44-54. (PMID: 24797783)
Eur J Med Chem. 2010 Apr;45(4):1395-402. (PMID: 20097456)
Org Biomol Chem. 2013 May 14;11(18):2972-8. (PMID: 23529416)
Neuropharmacology. 2010 Sep;59(3):172-9. (PMID: 20488195)
Org Lett. 2016 Nov 4;18(21):5756-5759. (PMID: 27783528)
Chemistry. 2020 Mar 2;26(13):2869-2882. (PMID: 31729785)
Org Biomol Chem. 2011 Mar 7;9(5):1301-13. (PMID: 21210032)
J Org Chem. 2015 Dec 18;80(24):12470-81. (PMID: 26561717)
Org Lett. 2014 Aug 15;16(16):4122-5. (PMID: 25060565)
ChemMedChem. 2017 Feb 3;12(3):235-249. (PMID: 27976818)
Eur J Med Chem. 2014 Nov 24;87:471-83. (PMID: 25282270)
Molecules. 2016 Nov 06;21(11):. (PMID: 27827970)
Physiol Behav. 2017 Mar 1;170:100-105. (PMID: 28012831)
Org Biomol Chem. 2016 Jun 28;14(24):5402-16. (PMID: 26892101)
Org Lett. 2020 Mar 20;22(6):2318-2322. (PMID: 32118452)
Chemistry. 2017 Oct 26;23(60):15080-15088. (PMID: 28857289)
J Org Chem. 2007 Aug 31;72(18):6726-34. (PMID: 17691736)
ACS Appl Mater Interfaces. 2019 Sep 25;11(38):35185-35192. (PMID: 31452373)
Org Lett. 2013 Apr 5;15(7):1744-7. (PMID: 23509894)
J Org Chem. 2016 Jun 3;81(11):4485-93. (PMID: 27191713)
Org Biomol Chem. 2015 May 28;13(20):5757-64. (PMID: 25902184)
Chem Commun (Camb). 2019 Jul 11;55(57):8258-8261. (PMID: 31243399)
Org Lett. 2016 Apr 1;18(7):1542-5. (PMID: 26974171)
Mol Cell Biochem. 2012 Jun;365(1-2):175-80. (PMID: 22350757)
Org Lett. 2017 Oct 6;19(19):5450-5453. (PMID: 28937223)
Bioorg Med Chem. 2011 Feb 15;19(4):1418-25. (PMID: 21288725)
Antioxidants (Basel). 2017 Mar 24;6(2):. (PMID: 28338603)
J Am Chem Soc. 2017 Jun 28;139(25):8552-8561. (PMID: 28548496)
Adv Sci (Weinh). 2019 Apr 26;6(13):1900245. (PMID: 31380184)
Grant Information:: 17/2551-0000964-9 Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul; 423245/2018-0 Conselho Nacional de Desenvolvimento Científico e Tecnológico; 001 Coordenação de Aperfeiçoamento de Pessoal de Nível Superior; 0726/13 Financiadora de Estudos e Projetos
Contributed Indexing:: Keywords: benzoselenophene; cyclization; organochalcogen; organoselenium; selenophene
Substance Nomenclature:: 0 (Heterocyclic Compounds)
0 (Organoselenium Compounds)
Entry Date(s):: Date Created: 20201216 Date Completed: 20210414 Latest Revision: 20240330
Update Code:: 20240330
PubMed Central ID:: PMC7764687
DOI:: 10.3390/molecules25245907
PMID:: 33322179
: Czasopismo naukowe

Pełny tekst

The selenophene derivatives are an important class of selenium-based heterocyclics. These compounds play an important role in prospecting new drugs, as well as in the development of new light-emitting materials. During the last years, several methods have been emerging to access the selenophene scaffold, employing a diversity of cyclization-based synthetic strategies, involving specific reaction partners and particularities. This review presents a comprehensive discussion on the recent advances in the synthesis of selenophene-based compounds, starting from different precursors, highlighting the main differences, the advantages, and limitations among them.

Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Informacja